Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma

clinical trial

Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT02293109

P6099clinical trial phasephase I clinical trialQ5452194
P17countryUnited States of AmericaQ30
P582end time2018-12-01
P4135maximum age64
P1050medical conditionleukemiaQ29496
lymphomaQ208414
P2899minimum age18
P1132number of participants21
P4844research interventiondoxorubicinQ18936
cytarabineQ180983
(RS)-cyclophosphamideQ408524
rituximabQ412323
calcium oxalateQ412399
methylprednisoloneQ417222
prednisoloneQ11426176
leucovorin calciumQ27077063
prednisolone acetateQ27108063
methylprednisolone hemisuccinateQ27262132
prednisolone 21-phosphateQ27266327
CaelyxQ29004943
P580start time2015-12-01
P8363study typeinterventional studyQ78089383
P1476titlePhase I Study of Escalating Doses of Carfilzomib With Hyper-CVAD in Patients With Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

Search more.